Galena Biopharma (GALE) Launches Galena Patient Services (GPS)
3/3/2014 8:52:30 AM
PORTLAND, Ore., March 3, 2014 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced the launch of Galena Patient Services (GPS), a full-service support program designed to enhance patient access to commercial products offered by the Company. Currently, Galena markets Abstral® (fentanyl) Sublingual Tablets for the treatment of breakthrough cancer pain.
Help employers find you! Check out all the jobs and post your resume.
comments powered by